Medical and nursing research offer immense, life-saving potential for changing how we prevent and treat illness and injuries, now and in the future.
Learn how you can help
This new glow is 100 times brighter than what scientists commonly use to track cancer tumors and other biological processes.
Mike McConnell, PhD, Assistant Professor of Biochemistry and Molecular Genetics, was interviewed by The Scientist this week. McConnell provided perspective on two recently published single-cell genome studies.
“What’s cool about [the papers] is that they show two different ways that one can look at somatic mutations in single human neurons . . . and yet they get consistent results . . . It’s very good news for folks like me that do single-cell sequencing," McConnell said.
Karen Wheeler, MD, Phd, has been awarded the prestigious AUA - Urology Care Foundation Grant! What follows is an excerpt from the letter that makes it official. Congratulations Dr. Wheeler!
"Dear Dr. Karen Wheeler, Congratulations! On behalf of the Urology Care Foundation and the American Urological Association (AUA) Office of Research, we are pleased to inform you that the application you submitted to the Urology Care Foundation 2018 Research Scholar Award Program was recommended for funding. Your application was selected from 77 applications submitted for this year’s competition based on your potential for a successful career in urologic research, the quality of the mentorship you will receive, and the high scientific merit of your proposed research project. Applications were reviewed by our Research Grants Review Panel comprised of leading experts in urologic research.
Carolyn J.M. Best, PhD Aria F. Olumi, MD
AUA Director, Office of Research"
Watch Neuro Central's interview with Jonathan Kipnis, Professor of Neuroscience and Director of the Center for Brain Immunology and Glia at UVA School of Medicine.
Chemotherapy and radiation therapy aren't the first line of treatment for certain cancers. This study suggests that sometimes they should be.
Researchers brought together a team of stakeholders, including prostate cancer patients and doctors, who concluded that patients need a personalized way to compare treatment options.